Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yael Eshet

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Hematological Oncology|November 21, 2024
Ibrutinib With Bendamustine and Rituximab for Treatment of Patients With Relapsed/Refractory Aggressive B-Cell LymphomaMeirav Kedmi, Elena Ribakovsy, Ohad Benjamini, et al.
Rheumatology (Oxford, England)|June 24, 2026
CAR-T as a salvage treatment in polyrefractory rheumatoid arthritisMerav Lidar, Paula David, Elad Jacoby, et al.
Blood Advances|November 20, 2020
A risk model for relapsed/refractory aggressive NHL integrating clinical risk factors and pretransplant Deauville scoreHo-Young Yhim, Yael Eshet, Ur Metser, et al.
Science (New York, N.Y.)|December 11, 2020
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patientsErez N Baruch, Ilan Youngster, Guy Ben-Betzalel, et al.
The Journal of Clinical Investigation|August 8, 2024
F18-FDG PET imaging as a diagnostic tool for immune checkpoint inhibitor-associated acute kidney injuryShruti Gupta, Olivia Green-Lingren, Sudhir Bhimaniya, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Hematological Oncology|November 21, 2024
Ibrutinib With Bendamustine and Rituximab for Treatment of Patients With Relapsed/Refractory Aggressive B-Cell LymphomaMeirav Kedmi, Elena Ribakovsy, Ohad Benjamini, et al.
Rheumatology (Oxford, England)|June 24, 2026
CAR-T as a salvage treatment in polyrefractory rheumatoid arthritisMerav Lidar, Paula David, Elad Jacoby, et al.
Blood Advances|November 20, 2020
A risk model for relapsed/refractory aggressive NHL integrating clinical risk factors and pretransplant Deauville scoreHo-Young Yhim, Yael Eshet, Ur Metser, et al.
Science (New York, N.Y.)|December 11, 2020
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patientsErez N Baruch, Ilan Youngster, Guy Ben-Betzalel, et al.
The Journal of Clinical Investigation|August 8, 2024
F18-FDG PET imaging as a diagnostic tool for immune checkpoint inhibitor-associated acute kidney injuryShruti Gupta, Olivia Green-Lingren, Sudhir Bhimaniya, et al.
Pageof 5